ProfileGDS4095 / 213023_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 35% 36% 36% 35% 36% 35% 34% 36% 35% 40% 34% 36% 36% 30% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.5585135
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.5627536
GSM709765LY2 SRC1-siRNA untreated rep32.5884436
GSM709771LY2 SRC1-siRNA untreated rep12.5447435
GSM709772LY2 SRC1-siRNA untreated rep22.5991736
GSM709775LY2 SRC1-siRNA untreated rep42.5509435
GSM709764LY2 control-siRNA tamoxifen treated rep22.507534
GSM709766LY2 control-siRNA tamoxifen treated rep32.6022236
GSM709768LY2 control-siRNA tamoxifen treated rep12.5408535
GSM709777LY2 control-siRNA tamoxifen treated rep42.7917540
GSM709770LY2 control-siRNA untreated rep32.4860634
GSM709773LY2 control-siRNA untreated rep12.6010436
GSM709774LY2 control-siRNA untreated rep22.5910936
GSM709776LY2 control-siRNA untreated rep42.3680930